Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
18.27
-0.35 (-1.88%)
At close: Aug 6, 2026, 4:00 PM EDT
18.39
+0.12 (0.66%)
Pre-market: Aug 7, 2026, 4:00 AM EDT
Erasca Market Cap
Erasca has a market cap or net worth of $6.34 billion as of August 6, 2026. Its market cap has increased by 1,392.48% in one year.
Market Cap
6.34B
Enterprise Value
5.98B
1-Year Change
1,392.48%
Ranking
Category
Stock Price
$18.27
ChartMarket Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $6.34B, an increase of 241.28%. That is a compound annual growth rate of 27.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 6.34B | 500.91% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| TG Therapeutics | 6.91B |
| Mirum Pharmaceuticals | 6.36B |
| CG Oncology | 6.30B |
| Xenon Pharmaceuticals | 6.19B |
| Belite Bio | 6.19B |
| Dianthus Therapeutics | 6.04B |
| Ligand Pharmaceuticals | 5.96B |
| Oruka Therapeutics | 5.92B |